Watch your brand wave by wave through the eyes of prescribers, payers and accounts: where it is gaining, where it is slipping, and the reason behind each shift.

Without the reason behind a dip in prescribing, the fix is a guess, and next quarter's budget follows the guess.
Brand tracking metrics for awareness, preference and access show shifts before they reach the prescribing numbers.
Each movement comes with the reason prescribers and payers give for it, so the fix targets the cause.
Shift field effort and spend toward the audiences and messages that are gaining ground.
Brand tracking research is the repeated measurement of how a brand is known, preferred and used, wave after wave, so changes show up against a fixed baseline. Nextyn tracks a pharma brand through interviews and surveys with the prescribers, payers and priority accounts the brand relies on, and names the reason behind each shift.

What you will knowThe audiences drifting away from your brand, and the competitor picking up what they leave.

What you will knowAwareness, preference and access from each survey wave, read against your launch plan, with every gap and its cause named.

What you will knowA short list of actions for each audience, tied to the signals that moved and why they moved.





What it settledInterviews with HCPs, payers and priority accounts compared competing brands on clinical confidence, access, service and messaging, revealing the perceived strengths to counter and the gaps the brand could credibly own.
Read the case study


Send us your question. We come back with a plan and a price. Nothing starts until you approve it.
What you need to know, which markets, and by when.
Who we will speak to, how, and what it costs. Inside 48 hours.
Nothing is commissioned until you say yes.
Every interview read together: where they agree, where they conflict, and what is still open.
Brand tracking research is the repeated measurement of how well a brand is known, preferred and used, taken in waves so each result is read against the last. In pharma, brand tracking means following three audiences (prescribers, payers and priority accounts) on brand tracking metrics such as awareness, preference, prescribing intent, access and competitor activity. Nextyn adds the reason behind each shift, drawn from interviews with the people who moved, so a dip in brand performance arrives with its cause.
A Nextyn brand health tracker delivers three outputs each wave: a brand momentum scorecard, the reasons behind each shift by audience, and actions tied to what moved. Every output comes from fresh interviews and surveys with prescribers, payers and accounts, not from sales data alone:
Nextyn interviews and surveys the three groups whose choices move a pharma brand: prescribing physicians, payers and priority accounts. The same profile is sampled in every wave, matched to the therapy area and the markets in scope, so each result compares like with like:
Nextyn runs brand tracking research in the United States, the United Kingdom, Germany, France, Italy and Spain, among other markets. Markets are agreed at scoping and held constant across waves, so each country's results are compared with its own earlier readings. Recent Nextyn pharma work includes a comparison of competing specialty-care brands in Europe on clinical confidence, access, service and messaging, drawn from interviews with HCPs, payers and priority accounts.
Nextyn recommends starting brand tracking research before launch, or before any change in pricing, messaging or competition that the brand team will need to explain later. A first wave taken early gives every later wave a baseline, so a shift in awareness, preference or access can be dated and traced to its cause. There are three other triggers for a first wave: a new competitor entry, a label or guideline change, and prescribing that has stalled without a clear reason.
A Nextyn brand tracking study runs in four steps, from brief to read-out, and nothing is commissioned until the client approves the plan. Nextyn designs the study around the decisions each wave must inform, so the client sees the sample, method and price before the first wave and reads every interview with the Nextyn team once results are in.
Nextyn sends a research plan within 48 hours of receiving the brief, stating who will be interviewed, how, and what the work costs. The plan sets the length of each wave and the gap between waves, matched to the brand's decision cycle, whether that is a launch year or steady-state management. Nothing is commissioned until the plan is approved, and the first wave sets the baseline that every later wave is read against.
Nextyn's brand tracking research explains why a brand's position is moving, using new evidence from its prescribers, payers and accounts, while prescription data records what was prescribed after the fact. The two work together for measuring brand performance: prescription data shows the result, and tracking shows the awareness, preference and access shifts that lead to it.
| Nextyn brand tracking | Prescription data | |
|---|---|---|
| Scope | One brand and its named competitors | Every product dispensed in a market |
| Evidence | Repeated interviews and surveys with HCPs, payers and accounts | Pharmacy and claims records |
| Output | Momentum scorecard, reasons for each shift and actions | Volumes and share over time |
| Timing | A research plan in 48 hours, then waves set to the decision cycle | Reported after prescriptions are filled |
Your privacy choices
We measure how this site is used and which campaigns bring people here. You can opt out at any time, which also stops any sale or sharing of your personal information for advertising.
Needed for the site to work — your session and your privacy choice itself. Always on.
How pages are found and read, so we can improve them. Never sold, never used to advertise to you.
Records how you move through a page so we can see what is confusing. Typing is masked, and the chat panel and every form are never recorded.
Lets us measure which campaigns bring people here, and show relevant messages elsewhere.